Oncology Research

Papers
(The TQCC of Oncology Research is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
MicroRNA-296 Targets Specificity Protein 1 to Suppress Cell Proliferation and Invasion in Cervical Cancer [Oncology Research 26(5) (2018) 775783]32
Identification of lncRNAs associated with T cells as potential biomarkers and therapeutic targets in lung adenocarcinoma23
Identification of a dihydroorotate dehydrogenase inhibitor that inhibits cancer cell growth by proteomic profiling20
ScRNA-seq reveals the correlation between M2 phenotype of tumor-associated macrophages and lymph node metastasis of breast cancer19
Retraction notice to Long Noncoding RNA MEG3 Inhibits Cell Proliferation and Metastasis in Chronic Myeloid Leukemia via Targeting miR-184 [Oncology Research 26(2) (2018) 297-305]19
Retraction notice to High Blood miR-802 Is Associated With Poor Prognosis in HCC Patients by Regulating DNA Damage Response 1 (REDD 1)-Mediated Function of T Cells [Oncology Research 27(9) (2019) 102519
YWHAH activates the HMGA1/PI3K/AKT/mTOR signaling pathway by positively regulating Fra-1 to affect the proliferation of gastric cancer cells18
Erratum: Programmed Death Ligand-1 (PD-L1) Regulated by NRF-2/MicroRNA-1 Regulatory Axis Enhances Drug Resistance and Promotes Tumorigenic Properties in Sorafenib-Resistant Hepatoma Cells17
()-Epigallocatechin-3-Gallate Inhibits EBV Lytic Replication via Targeting LMP1-Mediated MAPK Signal Axes17
Scaffold proteins of cancer signaling networks: The paradigm of FK506 binding protein 51 (FKBP51) supporting tumor intrinsic properties and immune escape16
mTORC2 promotes pancreatic cancer progression and parp inhibitor resistance16
Comprehensively analyzing the genetic alterations, and identifying key genes in ovarian cancer15
Neoadjuvant intermediate-course versus long-course chemoradiotherapy in T3-4/N0+ rectal cancer: Istanbul R-02 phase II randomized study15
Galectins dysregulation: A way for cancer cells to invade and pervade13
Changes of protein expression during tumorosphere formation of small cell lung cancer circulating tumor cells13
A Combined Chemical, Computational, and In Vitro Approach Identifies SBL-105 as Novel DHODH Inhibitor in Acute Myeloid Leukemia Cells12
Has_circ_0000069 expression in breast cancer and its influences on prognosis and cellular activities12
Long Noncoding RNA LAMTOR5-AS1 Interference Affects MicroRNA-506-3p/E2F6-Mediated Behavior of Non-Small Cell Lung Cancer Cells11
Inhibition of apoptosis-regulatory protein Siva-1 reverses multidrug resistance in gastric cancer by targeting PCBP110
The effect of Wnt/β-catenin signaling on PD-1/PDL-1 axis in HPV-related cervical cancer10
Targeting DNA repair for cancer treatment: Lessons from PARP inhibitor trials10
Konjac glucomannan enhances 5-FU-induced cytotoxicity of hepatocellular carcinoma cells via TLR4/PERK/CHOP signaling to induce endoplasmic reticulum stress10
Progress on diagnostic and prognostic markers of pancreatic cancer10
miR-142-5p Inhibits Cell Invasion and Migration by Targeting DNMT1 in Breast Cancer10
Transcriptome analysis reveals tumor antigen and immune subtypes of melanoma9
Tumor neoantigens: Novel strategies for application of cancer immunotherapy9
Erratum: Inhibition of Beclin-1-Mediated Autophagy by MicroRNA-17-5p Enhanced the Radiosensitivity of Glioma Cells8
Research Progress in Immunotherapy of NSCLC With EGFR-Sensitive Mutations8
MYCN Directly Targets NeuroD1 to Promote Cellular Proliferation in Neuroblastoma8
Review and prospect of immune checkpoint blockade therapy represented by PD-1/PD-L1 in the treatment of clear cell renal cell carcinoma8
Outcomes of Patients With Acute Myeloid Leukemia Who Relapse After 5 Years of Complete Remission8
Identification of a Novel Cancer Stemness-Associated ceRNA Axis in Lung Adenocarcinoma via Stemness Indices Analysis8
The anti-oncogenic effect of 17-DMAG via the inactivation of HSP90 and MET pathway in osteosarcoma cells8
Identification and verification of aging-related lncRNAs for prognosis prediction and immune microenvironment in patients with head and neck squamous carcinoma7
Comparison of UGT1A1 Polymorphism as Guidance of Irinotecan Dose Escalation in RAS Wild-Type Metastatic Colorectal Cancer Patients Treated With Cetuximab or Bevacizumab Plus FOLFIRI as t7
The remodeling roles of lipid metabolism in colorectal cancer cells and immune microenvironment7
Real-World Data: Fruquintinib in Treating Metastatic Colorectal Cancer7
LSM12 facilitates the progression of colorectal cancer by activating the WNT/CTNNB1 signaling pathway7
A Panel of Tumor Biomarkers to Predict Complete Pathological Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer7
1.3945569992065